EU and UK QPPV
Identification and evaluation of drugs safety signals
Qualified Person for Pharmacovigilance
The appointment of a European Union (EU) Qualified Person for Pharmacovigilance (QPPV) is a mandatory requirement for all medicinal products authorised within the EU and they are responsible for ensuring that the Marketing Authorisation Holder’s pharmacovigilance system is compliant with EU requirements. Outsourcing the QPPV function can provide a cost-effective solution to gaining access to the required expertise of a QPPV based within the EU. QVigilance can provide an experienced EU QPPV to support and oversee a client’s portfolio.
EU QPPV SERVICES
Our QPPVs will support and oversee the following activities:
Establishing and maintaining the PV system in the EU. Promoting, maintaining, and improving compliance with the European legal requirements.
Review and approval of protocols of any Post-Authorisation Safety Studies (PASS) conducted in the EU or pursuant to a RMP agreed in the EU, as well as maintaining awareness of any PASS requested by a Competent Authority (CA), including the results of such studies.
Oversee the safety profiles and any emerging safety concerns regarding the medicinal product(s) as covered by the PSMF. As well as maintaining awareness of any conditions or obligations adopted as part of the marketing authorisation and other commitments relating to the safety or the safe use of the product.
Maintaining awareness of risk minimisation measures for the medicinal product covered by the PSMF and having sufficient authority over the content of Risk Management Plan (RMP).
Ensure conduct of pharmacovigilance and submission of all PV related documents in accordance with the legal requirements and Good Pharmacovigilance Practices (GVP), including the correctness and completeness of pharmacovigilance data submitted to the competent authorities and to the European Medicines Agency (EMA).
Act as a single pharmacovigilance contact point for the CAs, EMA and inspection on a 24/7. Ensuring a full and prompt response to requests from the CAs in Member States and from the EMA for the provision of information related to the safety and risk management of the medicinal product(s). And providing input into the preparation of regulatory action in the EU in response to emerging safety concerns.
EU local pharmacovigilance representatives
In certain member states within the EU, there is a requirement for the nomination of a pharmacovigilance person at national level. The role of these local representatives (often referred to as local QPPVs or National Persons Responsible for Pharmacovigilance (NPRPs)), is to provide a local contact person for the National Competent Authority (NCA) in the member state who usually must be fluent in the language and may be required to be resident of that country. The local representative may also be required to oversee the local PV system for collection and reporting of safety information to the concerned NCA, monitor local (non-indexed) literature for relevant safety information and act as the contact person of regulatory inspections by the NCA.
QVigilance can not only offer support in understanding which EU countries require a local representative but can also provide a network of local representatives in these individual countries to meet any specific local pharmacovigilance requirements
QVigilance can provide or source Local QPPV in the following countries:
Belgium | France | Germany | Italy | Poland | Netherlands | Spain
NEED TO OUTSOURCE QPPV SERVICES?